CO as a cellular signaling molecule

Annual Review of Pharmacology and Toxicology

Volumn 46, Issue , 2006, Pages 411-449

  Kim, Hong Pyo ^a   Ryter, Stefan W ^a   Choi, Augustine M K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Carbon monoxide; Guanylate cyclase; Mitogen activated protein kinase; Stress response

Indexed keywords

BILIRUBIN; BILIVERDIN; CARBON MONOXIDE; CAVEOLIN 1; GUANYLATE CYCLASE; HEME OXYGENASE; IRON; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OXYGEN;

ANTIINFLAMMATORY ACTIVITY; CELL PROTECTION; CIRCADIAN RHYTHM; ENZYME ACTIVATION; ENZYME ACTIVITY; GROWTH REGULATION; HEME SYNTHESIS; HUMAN; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; OXYGEN SENSING; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; VASODILATATION;

ANIMALS; APOPTOSIS; CARBON MONOXIDE; HEME OXYGENASE-1; HEMEPROTEINS; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 33144468579     PISSN: 03621642     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.46.120604.141053     Document Type: Review

References (309)

1. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. 1987. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 84:9265-69
2. Sjöstrand T. 1949. Endogenous production of carbon monoxide in man under normal and pathophysiological conditions. Scand. J. Clin. Lab. Invest. 1:201-14
3. Coburn RF, Blakemore WS, Forster RE. 1963. Endogenous carbon monoxide production in man. J. Clin. Invest. 42:1172-78
4. Stipanuk MH, Beck PW. 1982. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem. J. 15:267-77
5. Boehning D, Snyder SH. 2003. Novel neural modulators. Annu. Rev. Neurosci. 26:105-31
6. Tenhunen R, Marver HS, Schmid R. 1968. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. USA 61:748-55
7. Vremen HJ, Wong RJ, Stevenson DK. 2000. Carbon monoxide in breath, blood, and other tissues. In Carbon Monoxide Toxicity, ed. DG Penney, pp. 19-60. Boca Raton, FL: CRC Press
8. Maines MD. 1997. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37:517-54
9. Tenhunen R, Ross ME, Marver HS, Schmid R. 1970. Reduced nicotinamide adenine dinucleotide phosphate dependent biliverdin reductase: partial purification and characterization. Biochemistry 9:298-323
10. Maines MD, Trakshel GM, Kutty RK. 1986. Characterization of two constitutive forms of rat liver microsomal heme oxygenase. J. Biol. Chem. 261:411-19
11. Ryter SW, Choi AM. 2005. Heme oxygenase-1: redox regulation of a stress protein in lung and cell culture models. Antioxid. Redox. Signal. 7:80-91
12. Foresti R, Green CJ, Motterlini R. 2004. Generation of bile pigments by haem oxygenase: a refined cellular strategy in response to stressful insults. Biochem. Soc. Symp. 71:177-92
13. Watts RN, Richardson DR. 2004. Differential effects on cellular iron metabolism of the physiologically relevant diatomic effector molecules, NO and CO, that bind iron. Biochim. Biophys. Acta 1692:1-15
14. Barinaga M. 1993. Carbon monoxide: killer to brain messenger in one step. Science 259:309
15. Von Berg R. 1999. Toxicology update. Carbon monoxide. J. Appl. Toxicol. 19:379-86
16. Coburn RF. 1979. Mechanisms of carbon monoxide toxicity. Prev. Med. 8:310-22
17. Ignarro LJ, Degnan JN, Baricos WH, Kadowitz PJ, Wolin MS. 1982. Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochim. Biophys. Acta 718:49-59
18. Furchgott RF, Jothianandan D. 1991. Endothelium-dependent and -independent vasodilation involving cyclic GMP: Relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 28:52-61
19. Morita T, Mitsialis SA, Koike H, Liu Y, Kourembanas S. 1997. Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J. Biol. Chem. 272:32804-9
20. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH. 1993. Carbon monoxide: a putative neural messenger. Science 259:381-84
21. Morita T, Perrella MA, Lee ME, Kourembanas S. 1995. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc. Natl. Acad. Sci. USA 92:1475-79
22. Morita T, Kourembanas S. 1995. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J. Clin. Invest. 96:2676-82
23. Boehning D, Moon C, Sharma S, Hurt KJ, Hester LD, et al. 2003. Carbon monoxide neurotransmission activated by CK2 phosphorylation of heme oxygenase 2. Neuron 40:129-37
24. Raub JA, Benignus VA. 2002. Carbon monoxide in the nervous system. Neurosci. Biobehav. Rev. 26:925-40
25. Johnson RA, Columbari E, Columbari DS, Lavesa M, Talman WT, Nasjletti A. 1997. Role of endogenous carbon monoxide in central regulation of arterial pressure. Hypertension 30:962-67
26. Caudill TKO, Resta TC, Kanagy NL, Walker BR. 1998. Role of endothelial carbon monoxide in attenuated vasoreactivity following chronic hypoxia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 275:R1025-30
27. Suematsu M, Kashiwagi S, Sano T, Goda N, Shinoda Y, Ishimura Y. 1994. Carbon monoxide as an endogenous modulator of hepatic vascular perfusion. Biochem. Biophys. Res. Commun. 205:1333-37
28. Wang R, Wu L, Wang Z. 1997. The direct effect of carbon monoxide on KCa channels in vascular smooth muscle cells. Phlügers Arch. 434:285-91
29. Leffler CW, Nasjletti A, Yu C, Johnson RA, Fedinec AL, Walker N. 1999. Carbon monoxide and cerebral microvascular tone in newborn pigs. Am. J. Physiol. Heart Circ. Physiol. 276:H1641-46
30. Kaide JI, Zhang F, Wei Y, Jiang JH, Yu C, et al. 2001. Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J. Clin. Invest. 107:1163-71
31. Kim HP, Wang X, Nakao A, Kim SI, Murase N, et al. 2005. Caveolin-1 expression by means of p38β mitogen-activated protein kinase mediates the antiproliferative effect of carbon monoxide. Proc. Natl. Acad. Sci. USA 102:11319-24
32. Duckers HJ, Boehm M, True AL, Yet SF, San H, et al. 2001. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat. Med. 7:693-98
33. Ndisang JF, Tabien HEN, Wang R. 2004. Carbon monoxide and hypertension. J. Hypertension 22:1057-74
34. Otterbein LE, Zuckerbraun BS, Haga M, Liu F, Song R, et al. 2003. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat. Med. 9:183-90
35. Brüne B, Ullrich V. 1987. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol. Pharmacol. 32:497-504
36. Fujita T, Toda K, Karimova A, Yan SF, Naka Y, et al. 2001. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat. Med. 7:598-604
37. Otterbein LE, Mantell LL, Choi AM. 1999. Carbon monoxide provides protection against hyperoxic lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 276:L688-94
38. Otterbein LE, Bach FH, Alam J, Soares MP, Tao Lu H, et al. 2000. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6:422-28
39. Soares MP, Lin Y, Anrather J, Csizmadia E, Takigami K, et al. 1998. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat. Med. 4:1073-77
40. Ryter S, Otterbein LE, Morse D, Choi AM. 2002. Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol. Cell. Biochem. 234-235:249-63
41. Kim HP, Wang X, Zhang J, Suh GY, Benjamin IJ, et al. 2005. Heat shock protein-70 mediates the cytoprotective effect of carbon monoxide: involvement of p3Sβ MAPK and heat shock factor-1. J. Immunol. 175:2622-29
42. Otterbein LE, Soares MP, Yamashita K, Bach FH. 2003. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24:449-55
43. Keyse SM, Applegate LA, Tromvoukis Y, Tyrrell RM. 1990. Oxidant stress leads to transcriptional activation of the human heme oxygenase gene in cultured skin fibroblasts. Mol. Cell Biol. 10:4967-69
44. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. 1987. Bilirubin is an antioxidant of possible physiological importance. Science 235:1043-46
45. Takahashi T, Morita K, Akagi R, Sassa S. 2004. Heme oxygenase-1: a novel therapeutic target in oxidative tissue injuries. Curr. Med. Chem. 11:1545-61
46. Lee TS, Chau LY. 2002. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 8:240-46
47. Visner GA, Lu F, Zhou H, Liu J, Kazemfar K, Agarwal A. 2003. Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells: implications in the antiproliferative response to rapamycin. Circulation 107:911-16
48. Koizumi T, Negishi M, Ichikawa A. 1992. Induction of heme oxygenase by delta 12-prostaglandin J2 in porcine aortic endothelial cells. Prostaglandins 43:121-31
49. Grosser N, Abate A, Oberle S, Vreman HJ, Dennery PA, et al. 2003. Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem. Biophys. Res. Commun. 308:956-60
50. Grosser N, Hemmerle A, Berndt G, Erdmann K, Hinkelmann U, et al. 2004. The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells. Free Rad. Biol. Med. 37:2064-71
51. Zhang B, Tanaka J, Yang L, Yang L, Sakanaka M, et al. 2004. Protective effect of vitamin E against focal brain ischemia and neuronal death through induction of target genes of hypoxia-inducible factor-1. Neuroscience 126:433-40
52. Zhuang H, Kim YS, Koehler RC, Dore S. 2003. Potential mechanism by which resveratrol, a red wine constituent, protects neurons. Ann. NY Acad. Sci. 993:276-86
53. Balogun E, Hoque M, Gong P, Killeen E, Green CJ, et al. 2003. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem. J. 371:887-95
54. Peyton KJ, Reyna SV, Chapman GB, Ensenat D, Liu XM, et al. 2002. Heme oxygenase-1 -derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. Blood 99:4443-48
55. Yang L, Quan S, Nasjletti A, Laniado-Schwartzman M, Abraham NG. 2004. Heme oxygenase-1 gene expression modulates angiotensin II-induced increase in blood pressure. Hypertension 43:1221-26
56. Roberts GP, Youn H, Kerby RL. 2004. CO-sensing mechanisms. Microbiol. Mol. Biol. Rev. 68:453-73
57. Stevenson TH, Gutierrez AF, Alderton WK, Lian L, Scrutton NS. 2001. Kinetics of CO binding to the haem domain of murine inducible nitric oxide synthase: differential effects of haem domain ligands. Biochem. J. 358:201-8
58. Ryter SW, Otterbein LE. 2004. Carbon monoxide in biology and medicine. Bioessays 26:270-80
59. Uchida T, Sato E, Sato A, Sagami I, Shimizu T, Kitagawa T. 2005. CO-dependent activity-controlling mechanism of heme-containing CO-sensor protein, neuronal PAS domain protein 2. J. Biol. Chem. 280:21358-68
60. Dioum EM, Rutter J, Tuckerman JR, Gonzalez G, Gilles-Gonzalez MA, McKnight SL. 2002. NPAS2: a gas-responsive transcription factor. Science 298:2385-87
61. Collier J, Vallance P. 1989. Second messenger role for NO widens to nervous and immune systems. Trends Pharmacol. Sci. 10:427-31
62. Kamisaki Y, Saheki S, Nakane M, Palmieri JA, Kuno T, et al. 1986. Soluble guanylate cyclase from rat lung exists as a heterodimer. J. Biol. Chem. 261:7236-41
63. Zabel U, Kleinschnitz C, Oh P, Nedvetsky P, Smolenski A, et al. 2002. Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide. Nat. Cell Biol. 4:307-11
64. Friebe A, Mullershausen F, Smolenski A, Walter U, Schultz G, Koesling D. 1998. YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets. Mol. Pharmacol. 54:962-67
65. Zhao Y, Brandish PE, Ballou DP, Marietta MA. 1999. A molecular basis for nitric oxide sensing by soluble guanylate cyclase. Proc. Natl. Acad. Sci. USA 96:14753-58
66. Carr HS, Tran D, Reynolds MF, Burstyn JN, Spiro TG. 2002. Activation of soluble guanylyl cyclase by four-coordinate metalloporphyrins: evidence for a role for porphyrin conformation. Biochemistry 41:10149-57
67. Vogel KM, Hu S, Spiro TG, Dierks EA, Yu AE, Burstyn JN. 1999. Variable forms of soluble guanylyl cyclase: protein-ligand interactions and the issue of activation by carbon monoxide. J. Biol. Inorg. Chem. 4:804-13
68. Utz J, Ullrich V. 1991. Carbon monoxide relaxes ilial smooth muscle through activation of guanylate cyclase. Biochem. Pharmacol. 41:1195-201
69. Ramos KS, Lin H, McGrath JJ. 1989. Modulation of cyclic guanosine monophosphate levels in cultured aortic smooth muscle cells by carbon monoxide. Biochem. Pharmacol. 38:1368-70
70. Cardell LO, Ueki IF, Stjarne P, Agusti C, Takeyama K, et al. 1998. Bronchodilatation in vivo by carbon monoxide, a cyclic GMP related messenger. Br. J. Pharmacol. 124:1065-68
71. Friebe A, Wedel B, Harteneck C, Foerster J, Schultz G, Koesling D. 1997. Functions of conserved cysteines of soluble guanylyl cyclase. Biochemistry 36:1194-98
72. Martin E, Czarnecki K, Jayaraman V, Murad F, Kincaid J. 2005. Resonance Raman and infrared spectroscopic studies of high-output forms of human soluble guanylyl cyclase. J. Am. Chem. Soc. 127:4625-31
73. Kharitonov VG, Sharma VS, Magde D, Koesling D. 1999. Kinetics and equilibria of soluble guanylate cyclase ligation by CO: effect of YC-1. Biochemistry 38:10699-706
74. Vincent SR, Das S, Maines MD. 1994. Brain heme oxygenase isoenzymes and nitric oxide synthase are co-localized in select neurons. Neuroscience 63:223-31
75. Yamanaka M, Yamabe K, Saitoh Y, Katoh-Semba R, Semba R. 1996. Immunohistochemical localization of heme oxygenase-2 in the rat cerebellum. Neurosci. Res. 24:403-7
76. Wang R, Wu L. 1997. The chemical modification of KCa channels by carbon monoxide in vascular smooth muscle cells. J. Biol. Chem. 272:8222-26
77. Liu H, Mount DB, Nasjletti A, Wang W. 1999. Carbon monoxide stimulates the apical 70-pS K+ channel of the rat thick ascending limb. J. Clin. Invest. 103:963-70
78. Kaasik K, Lee CC. 2004. Reciprocal regulation of haem biosynthesis and the circadian clock in mammals. Nature 430:467-71
79. Ben-Shlomo R, Akhtar RA, Collins BH, Judah DJ, Davies R, Kyriacou CP. 1995. Light pulse-induced heme and iron-associated transcripts in mouse brain: a microarray analysis. Chronobiol. Int. 22:455-71
80. Schibler U, Sassone-Corsi P. 2002. A web of circadian pacemakers. Cell 111:919-22
81. Storch KF, Lipan O, Leykin I, Viswanathan N, Davis FC, et al. 2002. Extensive and divergent circadian gene expression in liver and heart. Nature 417:78-83
82. Boehning D, Snyder SH. 2002. Circadian rhythms. Carbon monoxide and clocks. Science 298:2339-40
83. Zhou YD, Barnard M, Tian H, Li X, Ring HZ, et al. 1997. Molecular characterization of two mammalian bHLH-PAS domain proteins selectively expressed in the central nervous system. Proc. Natl. Acad. Sci. USA 94:713-18
84. Vitaterna MH, King DP, Chang AM, Kornhauser JM, Lowrey PL, et al. 1994. Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. Science 264:719-25
85. King DP, Zhao Y, Sangoram AM, Wilsbacher LD, Tanaka M, et al. 1997. Positional cloning of the mouse circadian clock gene. Cell 89:641-53
86. Rutter J, Reick M, Wu LC, McKnight SL. 2001. Regulation of Clock and NPAS2 DNA binding by the redox state of NAD cofactors. Science 293:510-14
87. Artinian LR, Ding JM, Gillette MU. 2001. Carbon monoxide and nitric oxide: interacting messengers in muscarinic signaling to the brain's circadian clock. Exp. Neurol. 171:293-300
88. Ewing JF, Maines MD. 1991. Rapid induction of heme oxygenase 1 mRNA and protein by hyperthermia in rat brain: heme oxygenase 2 is not a heat shock protein. Proc. Natl. Acad. Sci. USA 88:5364-68
89. Ryter SW, Morse D, Choi AM. 2004. Carbon monoxide: to boldly go where NO has gone before. Sci. STKE 230:RE6
90. Zhang X, Shan P, Otterbein LE, Alam J, Flavell RA, et al. 2003. Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3. J. Biol. Chem. 278:1248-58
91. Zhang X, Shan P, Alam J, Davis RJ, Flavell RA, Lee PJ. 2003. Carbon monoxide modulates Fas/Fas ligand, caspases, and Bcl-2 family proteins via the p38alpha mitogen-activated protein kinase pathway during ischemia-reperfusion lung injury. J. Biol. Chem. 278:22061-70
92. Zhang X, Shan P, Alam J, Fu XY, Lee PJ. 2005. Carbon monoxide differentially modulates STAT1 and STAT3 and inhibits apoptosis via a phosphadidylinositol 3-kinase/Akt and p38 kinase-dependent STAT3 pathway during anoxia-reoxygenation injury. J. Biol. Chem. 280:8714-21
93. Han J, Lee JD, Tobias PS, Ulevitch RJ. 1993. Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J. Biol. Chem. 268:25009-14
94. Han J, Lee JD, Bibbs L, Ulevitch RJ. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-11
95. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, et al. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-46
96. Jiang Y, Chen C, Li Z, Guo W, Gegner JA, et al. 1996. Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J. Biol. Chem. 271:17920-26
97. Lechner C, Zahalka MA, Giot JF, Moller NP, Ullrich A. 1996. ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc. Natl. Acad. Sci. USA 93:4355-59
98. Li Z, Jiang Y, Ulevitch RJ, Han J. 1996. The primary structure of p38 gamma: a new member of p38 group of MAP kinases. Biochem. Biophys. Res. Commun. 228:334-40
99. Jiang Y, Gram H, Zhao M, New L, Gu J, et al. 1997. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta. J. Biol. Chem. 272:30122-28
100. Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC, Young PR. 1997. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem. Biophys. Res. Commun. 235:533-38
101. Hanks SK, Hunter T. 1995. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 9:576-96
102. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, et al. 1994. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78:1027-37
103. Nebreda AR, Porras A. 2000. p38 MAP kinases: beyond the stress response. Trend Biochem. Sci. 25:257-60
104. Sweeney G, Somwar R, Ramlal T, Volchuk A, Ueyama A, Klip A. 1999. An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J. Biol. Chem. 274:10071-78
105. Heidenreich KA, Kummer JL. 1996. Inhibition of p38 mitogen-activated protein kinase by insulin in cultured fetal neurons. J. Biol. Chem. 271:9891-94
106. Zarubin T, Han J. 2005. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15:11-18
107. Kummer JL, Rao PK, Heidenreich KA. 1997. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem. 272:20490-94
108. Song R, Mahidhara RS, Zhou Z, Hoffman RA, Seol DW, et al. 2004. Carbon monoxide inhibits T lymphocyte proliferation via caspase-dependent pathway. J. Immunol. 172:1220-26
109. Pae HO, Oh GS, Choi BM, Chae SC, Kim YM, et al. 2004. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J. Immunol. 172:4744-51
110. Kume M, Yamamoto Y, Saad S, Gomi T, Kimoto S, et al. 1996. Ischemic preconditioning of the liver in rats: implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J. Lab. Clin. Med. 128:251-58
111. Van Molle W, Wielockx B, Mahieu T, Takada M, Taniguchi T, et al. 2002. HSP70 protects against TNF-induced lethal inflammatory shock. Immunity 16:685-95
112. Ravagnan L, Gurbuxani S, Susin SA, Maisse C, Daugas E, et al. 2001. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat. Cell Biol. 3:839-43
113. Trost SU, Omens JH, Karlon WJ, Meyer M, Mestril R, et al. 1998. Protection against myocardial dysfunction after a brief ischemic period in transgenic mice expressing inducible heat shock protein 70. J. Clin. Invest. 101:855-62
114. Meldrum KK, Burnett AL, Meng X, Missen R, Shaw MBK, et al. 2003. Liposomal delivery of heat shock protein 72 into renal tubular cells blocks nuclear factor-κB activation, tumor necrosis factor-α production, and subsequent ischemia-induced apoptosis. Circ. Res. 92:293-99
115. Wong HR, Ryan M, Wispe JR. 1997. The heat shock response inhibits inducible nitric oxide synthase gene expression by blocking I-κB degradation and NF-κB nuclear translocation. Biochem. Biophys. Res. Commun. 231:257-63
116. Amersi F, Shen XD, Anselmo D, Melinek J, Iyer S, et al. 2002. Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology 35:815-23
117. Yee AS, Paulson EK, McDevitt MA, Rieger-Christ K, Summerhayes I, et al. 2004. The HBP1 transcriptional repressor and the p38 MAP kinase: unlikely partners in G1 regulation and tumor suppression. Gene 336:1-13
118. Bulavin DV, Phillips C, Nannenga B, Timofeev O, Donehower LA, et al. 2004. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat. Genet. 36:343-50
119. Bulavin DV, Demidov ON, Saito S, Kauraniemi P, Phillips C, et al. 2002. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat Genet. 31:210-15
120. Takenaka K, Moriguchi T, Nishida E. 1998. Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest. Science 280:599-602
121. Molnar A, Theodoras AM, Zon LI, Kyriakis JM. 1997. Cdc42Hs, but not Rac1, inhibits serum-stimulated cell cycle progression at G1/S through a mechanism requiring p38/RK. J. Biol. Chem. 272:13229-35
122. Bulavin DV, Higashimoto Y, Popoff IJ, Gaarde WA, Basrur V, et al. 2001. Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 411:102-7
123. Faust D, Dolado I, Cuadrado A, Oesch F, Weiss C, et al. 2005. p38alpha MAPK is required for contact inhibition. Oncogene. In press
124. Lee PJ, Alam J, Wiegand GW, Choi AM. 1996. Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc. Natl. Acad. Sci. USA 93:10393-98
125. Timofeev O, Lee TY, Bulavin DV. 2005. A subtle change in p38 MAPK activity is sufficient to suppress in vivo tumorigenesis. Cell Cycle 4:118-20
126. Haq R, Brenton JD, Takahashi M, Finan D, Finkielsztein A, et al. 2002. Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. Cancer Res. 62:5076-82
127. Volonte D, Zhang K, Lisanti MP, Galbiati F. 2002. Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts. Mol. Biol. Cell. 13:2502-17
128. Brancho D, Tanaka N, Jaeschke A, Ventura JJ, Kelkar N, et al. 2003. Mechanism of p38 MAP kinase activation in vivo. Genes Dev. 17:1969-78
129. Park WY, Park JS, Cho KA, Kim DI, Ko YG, et al. 2000. Up-regulation of caveolin attenuates epidermal growth factor signaling in senescent cells. J. Biol. Chem. 275:20847-52
130. Exner M, Minar E, Wagner O, Schillinger M. 2004. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic. Biol. Med. 37:1097-104
131. Novotny L, Vitek L. 2003. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp. Biol. Med. 228:568-71
132. Nakao A, Murase N, Ho C, Toyogawa H, Billiar TR, et al. 2005. Biliverdin administration prevents the formation of intimal hyperplasia induced by vascular injury. Circulation 112:587-91
133. Ollinger R, Bilban M, Erat A, Froio A, McDaid J, et al. 2005. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 112:1030-39
134. Melichar VO, Behr-Roussel D, Zabel U, Uttenthal LO, Rodrigo J, et al. 2004. Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis. Proc. Natl. Acad. Sci. USA 101:16671-76
135. Chen S, Kapturczak MH, Wasserfall C, Glushakova OY, Campbell-Thompson M, et al. 2005. Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway. Proc. Natl. Acad. Sci. USA 102:7251-56
136. Burke SE, Lubbers NL, Chen YW, Hsieh GC, Mollison KW, et al. 1999. Neointimal formation after balloon-induced vascular injury in Yucatan minipigs is reduced by oral rapamycin. J. Cardiovasc. Pharmacol. 33:829-35
137. Shibata R, Kai H, Seki Y, Kusaba K, Takemiya K, et al. 2003. Rho-kinase inhibition reduces neointima formation after vascular injury by enhancing Bax expression and apoptosis. J. Cardiovasc. Pharmacol. 42(Suppl. 1):S43-47
138. Ivy DD, McMurtry IF, Colvin K, Imamura M, Oka M, et al. 2005. Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension. Circulation 111:2988-96
139. Choi MH, Lee IK, Kim GW, Kim BU, Han YH, et al. 2005. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 435:347-53
140. Lijnen HR. 2003-2004. Metalloproteinases in development and progression of vascular disease. Pathophysiol. Haemost. Thromb. 33:275-81
141. Ramirez Correa GA, Zacchigna S, Arsic N, Zentilin L, Salvi A, et al. 2004. Potent inhibition of arterial intimal hyperplasia by TIMP1 gene transfer using AAV vectors. Mol. Ther. 9:876-84
142. Hassan GS, Jasmin JF, Schubert W, Frank PG, Lisanti MP. 2004. Caveolin-1 deficiency stimulates neointima formation during vascular injury. Biochemistry 43:8312-21
143. Bergdahl A, Sward K. 2004. Caveolae-associated signaling in smooth muscle. Can. J. Physiol. Pharmacol. 82:289-99
144. Navarro A, Anand-Apte B, Parat M-O. 2004. A role of caveolae in cell migration. FASEB J. 18:1801-11
145. Morse D, Pischke SE, Zhou Z, Davis RJ, Flavell RA, et al. 2003. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J. Biol. Chem. 278:36993-98
146. Wagener FA, Volk HD, Willis D, Abraham NG, Soares MP, et al. 2003. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol. Rev. 55:551-71
147. Brouard S, Otterbein LE, Anrather, Tobiasch E, Bach FH, et al. 2000. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J. Exp. Med. 192:1015-26
148. Brouard S, Berberat PO, Tobiasch E, Seldon MP, Bach FH, Soares MP. 2002. Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-κB to protect endothelial cells from tumor necrosis factor-α-mediated apoptosis. J. Biol. Chem. 277:17950-61
149. Petrache I, Otterbein LE, Alam J, Wiegand GW, Choi AM. 2000. Heme oxygenase-1 inhibits TNF-alpha-induced apoptosis in cultured fibroblasts. Am. J. Physiol. Lung Cell Mol. Physiol. 278:1312-19
150. Zuckerbraun BS, Billiar TR, Otterbein SL, Kim PK, Liu F. 2003. Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase-1. J. Exp. Med. 198:1707-16
151. Pileggi A, Cattan P, Berney T, Molano RD, Vizzardelli C, et al. 2001. HO-1 up-regulation protects the pancreatic cell line betaTC3 from cytokines and Fas-induced apoptosis. Transplant. Proc. 33:266-67
152. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. 1999. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10:387-98
153. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, et al. 1997. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275:90-94
154. Ge B, Gram H, Di Padova F, Huang B, New L, et al. 2002. MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha. Science 295:1291-94
155. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-64
156. Piccirillo CA, Shevach EM. 2004. Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin. Immunol. 16:81-88
157. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, et al. 1998. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10:1969-80
158. Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, et al. 2003. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J. Clin. Invest. 112:1437-43
159. Choi BM, Pae HO, Jeong YR, Kim YM, Chung HT. 2005. Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem. Biophys. Res. Commun. 327:1066-71
160. Bettelli E, Dastrange M, Oukka M. 2005. Foxp3 interacts with nuclear factor of activated T cells and NF-kB to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA 102:5138-43
161. Fontenot JD, Gavin MA, Rudensky AY. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4:330-36
162. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27:18-20
163. Ke B, Shen XD, Zhai Y, Gao F, Busuttil RW, et al. 2002. Heme oxygenase 1 mediates the immunomodulatory and antiapoptotic effects of interleukin 13 gene therapy in vivo and in vitro. Hum. Gene Ther. 13:1845-57
164. Katori M, Busuttil RW, Kupiec-Weglinski JW. 2002. Heme oxygenase-1 system in organ transplantation. Transplantation 74:905-12
165. McDaid J, Yamashita K, Chora A, Ollinger R, Strom TB, et al. 2005. Heme oxygenase-1 modulates the allo-immune response by promoting activation-induced cell death of T cells. FASEB J. 19:458-60
166. Pae HO, Oh GS, Choi BM, Chae SC, Chung HT. 2003. Differential expressions of heme oxygenase-1 gene in CD25-and CD25+ subsets of human CD4+ T cells. Biochem. Biophys. Res. Commun. 306:701-5
167. Thornton AM, Donovan EE, Piccirillo CA, Shevach EM. 2004. Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J. Immunol. 172:6519-23
168. Browning DD, McShane MP, Marty C, Ye RD. 2000. Nitric oxide activation of p38 mitogen-activated protein kinase in 293T fibroblasts requires cGMP-dependent protein kinase. J. Biol. Chem. 275:2811-16
169. Chiche JD, Schlutsmeyer SM, Bloch DB, de la Monte SM, Roberts JD Jr, et al. 1998. Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP. J. Biol. Chem. 273:34263-71
170. Williams SE, Wootton P, Mason HS, Bould J, Iles DE, et al. 2004. Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel. Science 306:2093-97
171. Jaggar JH, Leffler CW, Cheranov SY, Tcheranova D, Shuyu E, Cheng X. 2002. Carbon monoxide dilates cerebral arterioles by enhancing the coupling of Ca2+ sparks to Ca2+-activated K+ channels. Circ. Res. 91:610-17
172. Dubuis E, Potier M, Wang R, Vandier C. 2005. Continuous inhalation of carbon monoxide attenuates hypoxic pulmonary hypertension development presumably through activation of BKCa channels. Cardiovasc. Res. 65:751-61
173. Golub T, Wacha S, Caroni P. 2004. Spatial and temporal control of signaling through lipid rafts. Curr. Opin. Neurobiol. 14:542-50
174. Li H, Brodsky S, Basco M, Romanov V, De Angelis DA, Goligorsky MS. 2001. Nitric oxide attenuates signal transduction: possible role in dissociating caveolin-1 scaffold. Circ. Res. 88:229-36
175. Feron O, Kelly RA. 2001. The caveolar paradox. Suppressing, inducing, and terminating eNOS signaling. Circ. Res. 88:129-31
176. Pelkmans L, Fava E, Grabner H, Hannus M, Habermann B, et al. 2005. Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 436:78-86
177. Caselli A, Taddei ML, Manao G, Camici G, Ramponi G. 2001. Tyrosine-phosphorylated caveolin is a physiological substrate of the low M(r) protein-tyrosine phosphatase. J. Biol. Chem. 276:18849-54
178. Vargas MR, Pehar M, Cassina P, Martinez-Palma L, Thompson JA, et al. 2005. Fibroblast growth factor-1 induces heme oxygenase-1 via nuclear factor erythroid 2-related factor 2 (Nrf2) in spinal cord astrocytes: consequences for motor neuron survival. J. Biol. Chem. 280:25571-79
179. Tacchini L, De Ponti C, Matteucci E, Follis R, Desiderio MA. 2004. Hepatocyte growth factor-activated NF-kappaB regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines. Carcinogenesis 25:2089-100
180. Fernandez M, Bonkovsky HL. 2003. Vascular endothelial growth factor increases heme oxygenase-1 protein expression in the chick embryo chorioallantoic membrane. Br. J. Pharmacol. 139:634-40
181. Liu H, Nowak R, Chao W, Bloch KD. 2003. Nerve growth factor induces anti-apoptotic heme oxygenase-1 in rat pheocnromocytoma PC12 cells. J. Neurochem. 86:1553-63
182. Saunas M, Diaz R, Abraham NG, Ruiz de Galarreta CM, Cuadrado A. 2003. Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner. J. Biol. Chem. 278:13898-904
183. Ning W, Song R, Li C, Park E, Mohsenin A, 2002. TGF-beta1 stimulates HO-1 via the p38 mitogen-activated protein kinase in A549 pulmonary epithelial cells. Am. J. Physiol. 283:L1094-102
184. Braun S, Hanselmann C, Gassmann MG, auf dem Keller U, Born-Berclaz C, et al. 2002. Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol. Cell Biol. 22:5492-505
185. Gould SE, Day M, Jones SS, Dorai H. 2002. BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int. 61:51-60
186. Durante W, Peyton KJ, Schafer AI. 1999. Platelet-derived growth factor stimulates heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 19:2666-72
187. Deshane J, Wright M, Agarwal A. 2005. Heme oxygenase-1 expression in disease states. Acta. Biochim. Pol. 52:273-84
188. Lu A, Ran RQ, Clark J, Reilly M, Nee A, Sharp FR. 2002. 17-beta-estradiol induces heat shock proteins in brain arteries and potentiates ischemic heat shock protein induction in glia and neurons. J. Cereb. Blood Flow Metab. 22:183-95
189. Malaguarnera L, Imbesi RM, Scuto A, D'Amico F, Licata F, et al. 2004. Prolactin increases HO-1 expression and induces VEGF production in human macrophages. J. Cell Biochem. 93:197-206
190. Lam CW, Getting SJ, Perretti M. 2005. In vitro and in vivo induction of heme oxygenase 1 in mouse macrophages following melanocortin receptor activation. J. Immunol. 174:2297-304
191. Pomeraniec Y, Grion N, Gadda L, Pannunzio V, Podesta EJ, Cymeryng CB. 2004. Adrenocorticotropin induces heme oxygenase-1 expression in adrenal cells. J. Endocrinol. 180:113-24
192. Kiemer AK, Bildner N, Weber NC, Vollmar AM. 2003. Characterization of heme oxygenase 1 (heat shock protein 32) induction by atrial natriuretic peptide in human endothelial cells. Endocrinology 144:802-12
193. Martinez-Cruz F, Espinar A, Pozo D, Osuna C, Guerrero JM. 2002. Melatonin prevents focal rat cerebellum injury as assessed by induction of heat shock protein (HO-1) following subarachnoid injections of lysed blood. Neurosci. Lett. 331:208-10
194. Haugen EN, Croatt AJ, Nath KA. 2000. Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro. Kidney Int. 58:144-52
195. Acevedo CH, Ahmed A. 1998. Heme-oxygenase-1 inhibits human myometrial contractility via carbon monoxide and is upregulated by progesterone during pregnancy. J. Clin. Invest. 101:949-55
196. Raju VS, McCoubrey WK Jr, Maines MD. 1997. Regulation of heme oxygenase-2 by glucocorticoids in neonatal rat brain: characterization of a functional glucocorticoid response element. Biochim. Biophys. Acta 1351:89-104
197. Kutty RK, Maines MD. 1989. Selective induction of heme oxygenase-1 isozyme in rat testis by human chorionic gonadotropin. Arch. Biochem. Biophys. 268:100-7
198. Kim EH, Kim DH, Na HK, Surh YJ. 2004. Effects of cyclopentenone prostaglandins on the expression of heme oxygenase-1 in MCF-7 cells. Ann. NY Acad. Sci. 1030:493-500
199. Haloui M, Meilhac O, Jandrot-Perrus M, Michel JB. 2003. Atorvastatin limits the pro-inflammatory response of rat aortic smooth muscle cells to thrombin. Eur. J. Pharmacol. 474:175-84
200. Maines MD, Kappas A. 1976. Selenium regulation of hepatic heme metabolism: induction of delta-aminolevulinate synthase and heme oxygenase. Proc. Natl. Acad. Sci. USA 73:4428-31
201. Satoh T, Ishige K, Sagara Y. 2004. Protective effects on neuronal cells of mouse afforded by ebselen against oxidative stress at multiple steps. Neurosci. Lett. 371:1-5
202. Deng YM, Wu BJ, Witting PK, Stocker R. 2004. Probucol protects against smooth muscle cell proliferation by upregulating heme oxygenase-1. Circulation 110:1855-60
203. Choi BM, Kim YM, Jeong YR, Pae HO, Song CE, et al. 2004. Induction of heme oxygenase-1 is involved in anti-proliferative effects of paclitaxel on rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 321:132-37
204. Knowles HJ, Tian YM, Mole DR, Harris AL. 2004. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1 alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases. Circ. Res. 95:162-69
205. Liu XM, Peyton KJ, Ensenat D, Wang H, Schafer AI, et al. 2005. Endoplasmic reticulum stress stimulates heme oxygenase-1 gene expression in vascular smooth muscle. Role in cell survival. J. Biol. Chem. 280:872-77
206. Alam J. 1994. Multiple elements within the 5′ distal enhancer of the mouse heme oxygenase-1 gene mediate induction by heavy metals. J Biol Chem. 269:25049-56
207. Ishikawa K, Navab M, Leitinger N, Fogelman AM, Lusis AJ. 1997. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J. Clin. Invest. 100:1209-16
208. Ishii T, Itoh K, Ruiz E, Leake DS, Unoki H, et al. 2004. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ. Res. 94:609-16
209. Kobayashi M, Yamamoto M. 2005. Molecular mechanisms activation of the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid. Redox Signal. 7:385-95
210. Foresti R, Clark JE, Green CJ, Motterlini R. 1997. Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells. Involvement of superoxide and peroxynitrite anions. J. Biol. Chem. 272:18411-17
211. Iles KE, Dickinson DA, Wigley AF, Welty NE, Blank V, Forman HJ. 2005. HNE increases HO-1 through activation of the ERK pathway in pulmonary epithelial cells. Free Radic. Biol. Med. 39:355-64
212. Kim do K, Kim JS, Kim JE, Kim SJ, Lee JS, et al. 2005. Heme oxygenase-1 induction by dieldrin in dopaminergic cells. Neuroreport 16:509-12
213. Muller T, Gebel S. 1994. Heme oxygenase expression in Swiss 3T3 cells following exposure to aqueous cigarette smoke fractions. Carcinogenesis 15:67-72
214. Liu LG, Yan H, Zhang W, Yao P, Zhang XP, et al. 2004. Induction of heme oxygenase-1 in human hepatocytes to protect them from ethanol-induced cytotoxicity. Biomed. Environ. Sci. 17:315-26
215. Liby K, Hock T, Yore MM, Suh N, Place AE, et al. 2005. The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling. Cancer Res. 65:4789-98
216. Chow JM, Shen SC, Huan SK, Lin HY, Chen YC. 2005. Quercetin, but not rutin and quercitrin, prevention of H2O2-induced apoptosis via anti-oxidant activity and heme oxygenase 1 gene expression in macrophages. Biochem. Pharmacol. 69:1839-51
217. Zurich MG, Lengacher S, Braissant O, Monnet-Tschudi F, Pellerin L, Honegger P. 2005. Unusual astrocyte reactivity caused by the food mycotoxin ochratoxin A in aggregating rat brain cell cultures. Neuroscience 134:771-82
218. Sultana R, Ravagna A, Mohmmad-Abdul H, Calabrese V, Butterfield DA. 2005. Ferulic acid ethyl ester protects neurons against amyloid beta-peptide(1-42)- induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J. Neurochem. 92:749-58
219. Nakamura Y, Yoshida C, Murakami A, Ohigashi H, Osawa T, Uchida K. 2004. Zerumbone, a tropical ginger sesquiterpene, activates phase II drug metabolizing enzymes. FEBS Lett. 572:245-50
220. Rieder CR, Williams AC, Ramsden DB. 2004. Selegiline increases heme oxygenase-1 expression and the cytotoxicity produced by dopamine treatment of neuroblastoma SK-N-SH cells. Braz. J. Med. Biol. Res. 37:1055-62
221. Tron K, Novosyadlyy R, Dudas J, Samoylenko A, Kietzmann T, Ramadori G. 2005. Upregulation of heme oxygenase-1 gene by turpentine oil-induced localized inflammation: involvement of interleukin-6. Lab. Invest. 85:376-87
222. Kweon MH, Jung MJ, Sung HC. 2004. Cytoprotective effects of heme oxygenase-1 induction by 3-O-caffeoyl-1-methylquinic acid. Free. Radic. Biol. Med. 36:40-52
223. Gong P, Hu B, Cederbaum AI. 2004. Di-allyl sulfide induces heme oxygenase-1 through MAPK pathway. Arch. Biochem. Biophys. 432:252-60
224. Foresti R, Hoque M, Monti D, Green CJ, Motterlini R. 2005. Differential activation of heme oxygenase-1 by chalcones and rosolic acid in endothelial cells. J. Pharmacol. Exp. Ther. 312:686-93
225. Schmidt R, Hoetzel A, Baechle T, Loop T, Humar M, et al. 2004. Isoflurane pre-treatment lowers portal venous resistance by increasing hepatic heme oxygenase activity in the rat liver in vivo. J. Hepatol. 41:706-13
226. Olszanecki R, Marcinkiewicz J. 2004. Taurine chloramine and taurine bromamine induce heme oxygenase-1 in resting and LPS-stimulated J774.2 macrophages. Amino Acids 27:29-35
227. Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B. 2002. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem. Toxicol. 40:1155-63
228. Haridas V, Hanausek M, Nishimura G, Soehnge H, Gaikwad A, et al. 2004. Triterpenoid electrophiles (avicins) activate the innate stress response by redox regulation of a gene battery. J. Clin. Invest. 113:65-73
229. Juan SH, Cheng TH, Lin HC, Chu YL, Lee WS. 2005. Mechanism of concentration-dependent induction of heme oxygenase-1 by resveratrol in human aortic smooth muscle cells. Biochem. Pharmacol. 69:41-48
230. Attuwaybi B, Kozar RA, Gates KS, Moore-Olufemi S, Sato N, et al. 2004. Hypertonic saline prevents inflammation, injury, and impaired intestinal transit after gut ischemia/reperfusion by inducing heme oxygenase 1 enzyme. J. Trauma. 56:749-58
231. Takeda K, Lin J, Okubo S, Akazawa-Kudoh S, Kajinami K, et al. 2004. Transient glucose deprivation causes up-regulation of heme oxygenase-1 and cyclooxygenase-2 expression in cardiac fibroblasts. J. Mol. Cell Cardiol. 36:821-30
232. Christou H, Bailey N, Kluger MS, Mitsialis SA, Kourembanas S. 2005. Extracellular acidosis induces heme oxygenase-1 expression in vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 288:H2647-52
233. Durante W, Kroll MH, Christodoulides N, Peyton KJ, Schafer AI. 1997. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ. Res. 80:557-64
234. Marquis JC, Demple B. 1998. Complex genetic response of human cells to sublethal levels of pure nitric oxide. Cancer Res. 58:3435-40
235. Foresti R, Sarathchandra P, Clark JE, Green CJ, Motterlini R. 1999. Peroxynitrite induces haem oxygenase-1 in vascular endothelial cells: a link to apoptosis. Biochem. J. 339:729-36
236. Naughton P, Foresti R, Bains SK, Hoque M, Green CJ, Motterlini R. 2002. Induction of heme oxygenase 1 by nitrosative stress. A role for nitroxyl anion. J. Biol. Chem. 277:40666-74
237. Naughton P, Hoque M, Green CJ, Foresti R, Motterlini R. 2002. Interaction of heme with nitroxyl or nitric oxide amplifies heme oxygenase-1 induction: involvement of the transcription factor Nrf2. Cell. Mol. Biol. 48:885-94
238. Choi BM, Pae HO, Chung HT. 2003. Nitric oxide priming protects nitric oxide-mediated apoptosis via heme oxygenase-1 induction. Free Radic. Biol. Med. 34:1136-45
239. Hartsfield CL, Alam J, Cook JL, Choi AM. 1997. Regulation of heme oxygenase-1 gene expression in vascular smooth muscle cells by nitric oxide. Am. J. Physiol. Lung Cell Mol. Physiol. 273:L980-88
240. Motterlini R, Foresti R, Intaglietta M, Winslow RM. 1996. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am. J. Physiol. Heart Circ. Physiol. 270:H107-14
241. Yee EL, Pitt BR, Billiar TR, Kim YM. 1996. Effect of nitric oxide on heme metabolism in pulmonary artery endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 271:L512-18
242. Pae HO, Choi BM, Oh GS, Lee MS, Ryu DG, et al. 2004. Roles of heme oxygenase-1 in the antiproliferative and antiapoptotic effects of nitric oxide on Jurkat T cells. Mol. Pharmacol. 66:122-28
243. Malaguarnera L, Imbesi R, Di Rosa M, Scuto A, Castrogiovanni P, et al. 2005. Action of prolactin, IFN-γ, TNF-α and LPS on heme oxygenase-1 expression and VEGF release in human monocytes/macrophages. Int. Immunopharmacol. 5:1458-69
244. Chen XL, Varner SE, Rao AS, Grey JY, Thomas S, et al. 2003. Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. J. Biol. Chem. 278:703-11
245. Wagner CT, Durante W, Christodoulides N, Hellums JD, Schafer AI. 1997. Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J. Clin. Invest. 100:589-96
246. Berger SP, Hunger M, Yard BA, Schnuelle P, Van Der Woude FJ. 2000. Dopamine induces the expression of heme oxygenase-1 by human endothelial cells in vitro. Kidney Int. 58:2314-19
247. Chang YC, Lai CC, Lin LF, Ni WF, Tsai CH. 2005. The up-regulation of heme oxygenase-1 expression in human gingival fibroblasts stimulated with nicotine. J. Periodontal Res. 40:252-57
248. Ham D, Schipper HM. 2000. Heme oxygenase-1 induction and mitochondrial iron sequestration in astroglia exposed to amyloid peptides. Cell Mol. Biol. 46:587-96
249. Chopra VS, Chalifour LE, Schipper HM. 1995. Differential effects of cysteamine on heat shock protein induction and cytoplasmic granulation in astrocytes and glioma cells. Brain Res. Mol. Brain Res. 31:173-84
250. Vile GF, Tyrrell RM. 1993. Oxidative stress resulting from ultraviolet-A irradiation of human skin fibroblasts leads to a heme oxygenase-dependent increase in ferritin. J. Biol. Chem. 268:14678-81
251. Galbraith RA, Drummond GS, Krey L, Kappas A. 1987. Relationship of suppression of the androgenic axis by cobalt-protoporphyrin to its effects on weight loss and hepatic heme oxygenase induction. Pharmacology 34:241-49
252. Wu WT, Chi KH, Ho FM, Tsao WC, Lin WW. 2004. Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition. Biochem. J. 379:587-93
253. Couet J, Sargiacomo M, Lisanti MP. 1997. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem. 272:30429-38
254. Cho CH, Lee CS, Chang M, Jang IH, Kim SJ, et al. 2004. Localization of VEGFR-2 and PLD2 in endothelial caveolae is involved in VEGF-induced phosphorylation of MEK and ERK. Am. J. Physiol. Heart Circ. Physiol. 286(5):H1881-88
255. Razani B, Zhang XL, Bitzer M, von Gersdorff G, Bottinger EP, Lisanti MP. 2001. Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor. J. Biol. Chem. 276:6727-38
256. Smith RM, Harada S, Smith JA, Zhang S, Jarett L. 1998. Insulin-induced protein tyrosine phosphorylation cascade and signalling molecules are localized in a caveolin-enriched cell membrane domain. Cell Signal. 10:355-62
257. Liu P, Ying Y, Ko YG, Anderson RG. 1996. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J. Biol. Chem. 271:10299-303
258. Bilderback TR, Gazula VR, Lisanti MP, Dobrowsky RT. 1999. Caveolin interacts with Trk A and p75(NTR) and regulates neurotrophin signaling pathways. J. Biol. Chem. 274:257-63
259. Ishizaka N, Griendling KK, Lassegue B, Alexander RW. 1998. Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension 32:459-66
260. Ko YG, Lee JS, Kang YS, Ahn JH, Seo JS. 1999. TNF-alpha-mediated apoptosis is initiated in caveolae-like domains. J. Immunol. 162:7217-23
261. Guignot J, Bernet-Camard MF, Pous C, Plancon L, Le Bouguenec C, Servin AL. 2001. Polarized entry of uropathogenic Afa/Dr diffusely adhering Escherichia coli strain IH11128 into human epithelial cells: evidence for alpha5beta1 integrin recognition and subsequent internalization through a pathway involving caveolae and dynamic unstable microtubules. Infect. Immun. 69:1856-68
262. Gingras D, Gauthier F, Lamy S, Desrosiers RR, Beliveau R. 1998. Localization of RhoA GTPase to endothelial caveolae-enriched membrane domains. Biochem. Biophys. Res. Commun. 247:888-93
263. Michaely PA, Mineo C, Ying YS, Anderson RG. 1999. Polarized distribution of endogenous Rac1 and RhoA at the cell surface. J. Biol. Chem. 274:21430-36
264. Chun M, Liyanage UK, Lisanti MP, Lodish HF. 1994. Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin. Proc. Natl. Acad. Sci. USA 91:11728-32
265. Annabi B, Lachambre M, Bousquet-Gagnon N, Page M, Gingras D, Beliveau R. 2001. Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains. Biochem. J. 353:547-53
266. Puyraimond A, Fridman R, Lemesle M, Arbeille B, Menashi S. 2001. MMP-2 colocalizes with caveolae on the surface of endothelial cells. Exp. Cell Res. 262:28-36
267. Schwab W, Gavlik JM, Beichler T, Funk RH, Albrecht S, et al. 2001. Expression of the urokinase-type plasminogen activator receptor in human articular chondrocytes: association with caveolin and beta 1-integrin. Histochem. Cell Biol. 115:317-23
268. Carlin SM, Resink TJ, Tamm M, Roth M. 2005. Urokinase signal transduction and its role in cell migration. FASEB J. 19:195-202
269. Razani B, Rubin CS, Lisanti MP. 1999. Regulation of cAMP-mediated signal transduction via interaction of caveolins with the catalytic subunit of protein kinase A. J. Biol. Chem. 274:26353-60
270. Tang ZL, Scherer PE, Lisanti MP. 1994. The primary sequence of murine caveolin reveals a conserved consensus site for phosphorylation by protein kinase C. Gene 147:299-300
271. Ju H, Venema VJ, Liang H, Harris MB, Zou R, Venema RC. 2000. Bradykinin activates the Janus-activated kinase/signal transducers and activators of transcription (JAK/STAT) pathway in vascular endothelial cells: localization of JAK/STAT signalling proteins in plasmalemmal caveolae. Biochem. J. 351:257-64
272. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG. 1992. Caveolin, a protein component of caveolae membrane coats. Cell 68:673-82
273. Bickel PE, Scherer PE, Schnitzer JE, Oh P, Lisanti MP, Lodish HF. 1997. Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J. Biol. Chem. 272:13793-802
274. Salzer U, Prohaska R. Stomatin 2002. Flotillin-1 and flotillin-2 are major integral proteins of erythrocyte lipid rafts. Blood 2001 97:1141-43
275. Pelkmans L, Puntener D, Helenius A. 2002. Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science 296:535-39
276. Kanzaki M, Pessin JE. 2002. Caveolin-associated filamentous actin (Cav-actin) defines a novel F-actin structure in adipocytes. J. Biol. Chem. 277:25867-69
277. Volonte D, Galbiati F, Pestell RG, Lisanti MP. 2001. Cellular stress induces the tyrosine phosphorylation of caveolin-1 (Tyr(14)) via activation of p38 mitogen-activated protein kinase and c-Src kinase. Evidence for caveolae, the actin cytoskeleton, and focal adhesions as mechanical sensors of osmotic stress. J. Biol. Chem. 276:8094-103
278. Takenouchi T, Miyashita N, Ozutsumi K, Rose MT, Aso H. 2004. Role of caveolin-1 and cytoskeletal proteins, actin and vimentin, in adipogenesis of bovine intramuscular preadipocyte cells. Cell Biol. Int. 28:615-23
279. Yao Q, Chen J, Cao H, Orth JD, McCaffery JM, et al. 2005. Caveolin-1 interacts directly with dynamin-2. J. Mol. Biol. 348:491-501
280. Dessy C, Kelly RA, Balligand JL, Feron O. 2000. Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling. EMBO J. 19:4272-80
281. Oh P, McIntosh DP, Schnitzer JE. 1998. Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J. Cell Biol. 141:101-14
282. Fujimoto T. 1993. Calcium pump of the plasma membrane is localized in caveolae. J. Cell Biol. 120:1147-57
283. Fujimoto T, Miyawaki A, Mikoshiba K. 1995. Inositol 1,4,5-trisphosphate receptor-like protein in plasmalemmal caveolae is linked to actin filaments. J. Cell Sci. 108:7-15
284. Murakami M, Nakatani Y, Kuwata H, Kudo I. 2000. Cellular components that functionally interact with signaling phospholipase A(2)s. Biochim. Biophys. Acta 1488159-66
285. Kim HP, Lee JY, Jeong JK, Bae SW, Lee HK, Jo I. 1999. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha localized in caveolae. Biochem. Biophys. Res. Commun. 263:257-62
286. McDonald KK, Zharikov S, Block ER, Kilberg MS. 1997. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox." J. Biol. Chem. 272:31213-16
287. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, et al. 1996. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J. Biol. Chem. 271:6518-22
288. Garcia-Cardena G, Oh P, Liu J, Schnitzer JE, Sessa WC. 1996. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc. Natl. Acad. Sci. USA 93:6448-53
289. Teubl M, Groschner K, Kohlwein SD, Mayer B, Schmidt K. 1999. Na(+)/ Ca(2+) exchange facilitates Ca(2+)-dependent activation of endothelial nitric-oxide synthase. J. Biol. Chem. 274:29529-35
290. de Weerd WF, Leeb-Lundberg LM. 1997. Bradykinin sequesters B2 bradykinin receptors and the receptor-coupled Galpha subunits Galphaq and Galphai in caveolae in DDT1 MF-2 smooth muscle cells. J. Biol. Chem. 272:17858-66
291. Jung NH, Kim HP, Kim BR, Cha SH, Kim GA, et al. 2003. Evidence for heme oxygenase-1 association with caveolin-1 and -2 in mouse mesangial cells. IUBMB Life 55:525-32
292. Kim HP, Wang X, Galbiati F, Ryter SW, Choi AM. 2004. Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. FASEB J. 18:1080-89
293. Mueller A, Kelly E, Strange PG. 2002. Pathways for internalization and recycling of the chemokine receptor CCR5. Blood 99:785-91
294. Soong G, Reddy B, Sokol S, Adamo R, Prince A. 2004. TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. J. Clin. Invest. 113:1482-89
295. Flemming JA, Perkins KH, Luus L, Ferguson AR, Corley RB. 2004. Disruption of membrane cholesterol stimulates MyD88-dependent NF-kappaB activation in immature B cells. Cell Immunol. 229:68-77
296. Dai Q, Zhang J, Pruett SB. 2005. Ethanol alters cellular activation and CD14 partitioning in lipid rafts. Biochem. Biophys. Res. Commun. 332:37-42
297. Brainard AM, Miller AJ, Martens JR, England SK. 2005. Maxi-K channels localize to caveolae in human myometrium: a role for an actin-channel-caveolin complex in the regulation of myometrial smooth muscle K+ current. Am. J. Physiol. Cell Physiol. 289:C49-57
298. Wang XL, Ye D, Peterson TE, Cao S, Shah VH, et al. 2005. Caveolae targeting and regulation of large conductance Ca(2+)-activated K+ channels in vascular endothelial cells. J. Biol. Chem. 280:11656-64
299. Bergdahl A, Gomez MF, Dreja K, Xu SZ, Adner M, et al. 2003. Cholesterol depletion impairs vascular reactivity to endothelin-1 by reducing store-operated Ca2+ entry dependent on TRPC1. Circ. Res. 93:839-47
300. Schnitzer JE, Oh P, Jacobson BS, Dvorak AM. 1995. Caveolae from luminal plasmalemma of rat lung endothelium: microdomains enriched in caveolin, Ca(2+)-ATPase, and inositol trisphosphate receptor. Proc. Natl. Acad. Sci. USA 92:1759-63
301. Huang C, Hepler JR, Chen LT, Gilman AG, Anderson RG, Mumby SM. 1997. Organization of G proteins and adenylyl cyclase at the plasma membrane. Mol. Biol. Cell 8:2365-78
302. Kang YH, West WL, George M. 1983. Ultracytochemical localization of guanylate cyclase in the oviduct of estrogen-stimulated rat. Anat. Rec. 205:251-62
303. Liu L, Mohammadi K, Aynafshar B, Wang H, Li D, et al. 2003. Role of caveolae in signal-transducing function of cardiac Na+/K+-ATPase. Am. J. Physiol. Cell Physiol. 284:C1550-60
304. Scherer PE, Lisanti MP, Baldini G, Sargiacomo M, Mastick CC, Lodish HF. 1994. Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J. Cell Biol. 127:1233-43
305. Acevedo L, Yu J, Erdjument-Bromage H, Miao RQ, Kim JE, et al. 2004. A new role for Nogo as a regulator of vascular remodeling. Nat. Med. 10:382-88
306. Spisni E, Griffoni C, Santi S, Riccio M, Marulli R, et al. 2001. Colocalization prostacyclin (PGI2) synthase-caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis. Exp. Cell Res. 266:31-43
307. Sargiacomo M, Sudol M, Tang Z, Lisanti MP. 1993. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J. Cell Biol. 122:789-807
308. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP. 1996. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J. Biol. Chem. 271:9690-97
309. Dorahy DJ, Lincz LF, Meldrum CJ, Burns GF. 1996. Biochemical isolation of a membrane microdomain from resting platelets highly enriched in the plasma membrane glycoprotein CD36. Biochem. J. 319:67-72